Beardmore W B, Jones K V, Clark T D, Hebeka E K
Appl Microbiol. 1968 Apr;16(4):563-8. doi: 10.1128/am.16.4.563-568.1968.
Serum is commonly treated with potassium periodate to destroy nonspecific inhibitors of influenza virus hemagglutination. We have observed, however, that such treatment of serum without pre-existing inhibitor produced high titers of inhibitor against certain strains of influenza virus. Inhibitor was induced in the serum from several different animal species but not in hamster or mouse serum. Periodate treatment of serum albumin, fraction V, from several animals, including man, creates this inhibitor. Our data indicate that the inhibitor induced in the serum of various animal species differs in its mechanism of induction and in its resistance to receptor-destroying enzyme and trypsin. Hemagglutination by B/Singapore/3/64, B/Colorado/2/65, B/Georgia/1/65, and B/Massachusetts/3/66 strains of influenza virus is inhibited by periodate-treated human serum at dilutions as high as 1:5,120. The routine use of periodate treatment of serum in diagnostic and surveillance studies of influenza virus infections is not recommended.
血清通常用高碘酸钾处理,以破坏流感病毒血凝反应的非特异性抑制剂。然而,我们观察到,对不存在预先存在抑制剂的血清进行这种处理会产生针对某些流感病毒株的高滴度抑制剂。在几种不同动物物种的血清中可诱导产生抑制剂,但在仓鼠或小鼠血清中则不会。对包括人在内的几种动物的血清白蛋白V组分进行高碘酸钾处理会产生这种抑制剂。我们的数据表明,在各种动物物种血清中诱导产生的抑制剂在诱导机制、对受体破坏酶和胰蛋白酶的抗性方面存在差异。高碘酸钾处理过的人血清在高达1:5120的稀释度下可抑制B/新加坡/3/64、B/科罗拉多/2/65、B/佐治亚/1/65和B/马萨诸塞/3/66流感病毒株的血凝反应。不建议在流感病毒感染的诊断和监测研究中常规使用高碘酸钾处理血清。